APF Research International LLC working as a Site Management Organization (SMO) provides sponsors and CROs with a network of clinical research centers specialized in conducting Phase I, II, III and IV studies for the pharmaceutical industry.
Latin America region is considered one of the most attractive worldwide for conducting pharmaceutical clinical trials. Global pharmaceutical companies have been running studies Latin American countries due to having adopted the International Conference for Harmonization (ICH) Good Clinical Practice (GCP) guidelines, they have an easy access to diverse patient population and proper time frame regulatory approval.
Treatment-naive patients available in all therapeutic areas
Disease profiles and therapeutic standards resembling those of the US and Europe
Smaller number of clinical trials competing for the same patients, which guarantees more patients per site
High patient enrollment and retention rates due to close, trustful patient-doctor relationships.
Seasonal reversal, enabling continuous enrollment
Experience with FDA/ EMA, local regulatory inspections and sponsor audits
Proven high-quality data. Most of the clinical research conducted in the region is part of multinational, industry-sponsored clinical trial efforts for FDA and/or EMA submissions.
Laboratory staff with IATA certification and experience in PK sampling
Investigators & research staff with English language literacy
Expertise in working with IWRS and EDC systems
High standard communications and IT
Similar time Zone as the USA/Europe (0 – 5 hours difference)